Literature DB >> 1148513

Proceedings: Time-dependent potentiation and inhibition by 5-hydroxytryptamine of platelet aggregation induced by ADP.

F Michal, M Motamed.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1148513      PMCID： PMC1666591     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  3 in total

1.  Aggregation of blood platelets by adenosine diphosphate and its reversal.

Authors:  G V BORN
Journal:  Nature       Date:  1962-06-09       Impact factor: 49.962

2.  Effects of 5-hydroxytryptamine on platelet aggregation.

Authors:  H R Baumgartner; G V Born
Journal:  Nature       Date:  1968-04-13       Impact factor: 49.962

3.  Relative activities on and uptake by human blood platelets of 5-hydroxytryptamine and several analogues.

Authors:  G V Born; K Juengjaroen; F Michal
Journal:  Br J Pharmacol       Date:  1972-01       Impact factor: 8.739
  3 in total
  2 in total

1.  Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41,468), a selective 5-HT2-receptor antagonist. 1982.

Authors:  F de Clerck; J L David; P A Janssen
Journal:  Agents Actions       Date:  1994-12

2.  Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist.

Authors:  F de Clerck; J L David; P A Janssen
Journal:  Agents Actions       Date:  1982-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.